THE BURDEN OF OBESITY IN MEXICO- PREVALENCE, COMORBIDITIES, AND ASSOCIATIONS WITH QUALITY OF LIFE, RESOURCE UTILIZATION AND PRODUCTIVITY

Author(s)

DiBonaventura MD1, Le Lay A2, Fournier J2, Kull K2, Olmos HC3, Mille I3, Bjørke B2, Bakker E3, Ehrenreich A1
1Kantar Health, New York, NY, USA, 2Novo Nordisk A/S, Bagsværd, Denmark, 3Novo Nordisk A/S, Mexico City, Mexico

OBJECTIVES: This study investigated the effect of body mass index (BMI) and related comorbidities on quality of life, work productivity, activity impairment, healthcare resource utilization, and associated costs in Mexico.   METHODS: Data were collected using a cross-sectional survey of adults in Mexico (N=2,511) identified from a combination of Internet panels and offline recruitment.  Recruitment was made to ensure the demographic composition of the sample mimicked the total adult population. The analysis focused on respondents with normal weight (BMI≥18.5 & <25 kg/m), overweight (BMI≥25 & <30 kg/m), obesity class I (BMI≥30 & <35 kg/m), class II (BMI≥35 & <40 kg/m), or class III (BMI≥40 kg/m). Demographics, comorbidities (e.g., hypertension, dysglycaemia), health outcomes such as quality of life (EQ-5D), work productivity and activity impairment (WPAI questionnaire), healthcare resource utilization, and indirect costs were assessed.  Generalized linear models were used to test the association between BMI levels and health outcomes, controlling for covariates (e.g., age, sex, comorbidities). RESULTS: The sample was 50.6% male with a mean age of 40.7 years (SD=14.5); 38.3% were overweight and 24.4% reported a BMI≥30.  75.2% of individuals with BMI ≥35 had dysglycaemia (29.9% type 2 diabetes mellitus (T2DM) and 45.3% pre-diabetes). Increasing BMI was associated with significant impairment in quality of life (health utilities ranging from 0.84 for normal weight, down to 0.76 for people with BMI≥35). Increasing BMI was also associated with greater overall work impairment (from 18.8% up to 25.8%), activity impairment (from 15.8% up to 24.8%), and indirect costs (from 35122 MXN up to 48090 MXNs). A similar pattern of results was found in the T2DM, pre-diabetes, and hypertension subgroups. CONCLUSIONS: Results suggest a significant effect of increasing BMI and comorbidities on quality of life and work productivity.  Improvement in the management of the obesity epidemic could have significant benefits to the patient and society.

Conference/Value in Health Info

2015-09, ISPOR Latin America 2015, Santiago, Chile

Value in Health, Vol. 18, No. 7 (November 2015)

Code

PSY13

Topic

Economic Evaluation, Patient-Centered Research

Topic Subcategory

Health State Utilities, Patient-reported Outcomes & Quality of Life Outcomes, Work & Home Productivity - Indirect Costs

Disease

Diabetes/Endocrine/Metabolic Disorders

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×